Matches in SemOpenAlex for { <https://semopenalex.org/work/W2599957194> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- W2599957194 abstract "169 Background: Concurrent chemoradiotherapy(CCRT) has become a promising treatment for esophageal cancer. Mostly, however, 3 week or 4 week interval of conventional FP(5-fluorouracil plus cisplatin) regimen is adopted, which is usually associated with moderate to severe treatment-related toxicities. Studies about weekly regimen of FP CCRT are little known, thus we studied the efficaty, tolerability and toxicities of weekly FP CCRT regimen. Methods: From February 2010 to august 2015, Patients staging from I to III esophageal cancer(according to AJCC 7 th edition) were enrolled, who were received radiation therapy with dose of from 50.4Gy to 60Gy(5 days/week) and 5-FU 1000mg/BSA with cisplatin 30mg/BSA weekly. Results: From February 2010 to august 2015, 50 patients: male/female 47/3, median age 71.5 (47-78), all of 50 patients was squamous carcinoma, well/moderately differentiated carcinoma 1/18. 45 patients completed CRT without dose reduction, 9 patients received less than 6 cycles of chemotherapy, 4 patients received less than 50.4Gy of radiotherapy. Major toxicities of grade 3 or less were as follows: neutropenia 52%, thrombocytopenia 21%, nausea & vomiting 10%, fatigue 10%, anemia 5%. Toxicities over grade 4 was seen only in 1 patient. 15 patients showed complete response. The median overall survival was 10.67 months(4-48). The median disease-free survival was 16.9 months. Conclusions: Weekly regimen of concurrent CRT with 5-FU and cisplatin resulted in less toxicities over grade 3. Although, this regimen still showed non-inferiority to previous conventional 4 week-interval FP CCRT regimens in terms of PFS and OS. In this study, 82% of our patients had completed CCRT without any interruption. Hence, our results suggest that CRT with weekly 5-FU and cisplatin as definitive treatment for esophageal cancer could be a tolerable regimen." @default.
- W2599957194 created "2017-04-07" @default.
- W2599957194 creator A5014474281 @default.
- W2599957194 creator A5024828401 @default.
- W2599957194 creator A5027635849 @default.
- W2599957194 creator A5034636783 @default.
- W2599957194 creator A5080254016 @default.
- W2599957194 date "2017-02-01" @default.
- W2599957194 modified "2023-09-28" @default.
- W2599957194 title "The efficacy and feasibility of weekly 5-FU and cisplatin based radical concurrent chemoradiation therapy(CRT) in patients with esophageal cancer." @default.
- W2599957194 doi "https://doi.org/10.1200/jco.2017.35.4_suppl.169" @default.
- W2599957194 hasPublicationYear "2017" @default.
- W2599957194 type Work @default.
- W2599957194 sameAs 2599957194 @default.
- W2599957194 citedByCount "0" @default.
- W2599957194 crossrefType "journal-article" @default.
- W2599957194 hasAuthorship W2599957194A5014474281 @default.
- W2599957194 hasAuthorship W2599957194A5024828401 @default.
- W2599957194 hasAuthorship W2599957194A5027635849 @default.
- W2599957194 hasAuthorship W2599957194A5034636783 @default.
- W2599957194 hasAuthorship W2599957194A5080254016 @default.
- W2599957194 hasConcept C121608353 @default.
- W2599957194 hasConcept C126322002 @default.
- W2599957194 hasConcept C141071460 @default.
- W2599957194 hasConcept C143998085 @default.
- W2599957194 hasConcept C197934379 @default.
- W2599957194 hasConcept C2776694085 @default.
- W2599957194 hasConcept C2778239845 @default.
- W2599957194 hasConcept C2778375690 @default.
- W2599957194 hasConcept C2778424827 @default.
- W2599957194 hasConcept C2779742542 @default.
- W2599957194 hasConcept C2780456651 @default.
- W2599957194 hasConcept C2781413609 @default.
- W2599957194 hasConcept C509974204 @default.
- W2599957194 hasConcept C71924100 @default.
- W2599957194 hasConcept C90924648 @default.
- W2599957194 hasConceptScore W2599957194C121608353 @default.
- W2599957194 hasConceptScore W2599957194C126322002 @default.
- W2599957194 hasConceptScore W2599957194C141071460 @default.
- W2599957194 hasConceptScore W2599957194C143998085 @default.
- W2599957194 hasConceptScore W2599957194C197934379 @default.
- W2599957194 hasConceptScore W2599957194C2776694085 @default.
- W2599957194 hasConceptScore W2599957194C2778239845 @default.
- W2599957194 hasConceptScore W2599957194C2778375690 @default.
- W2599957194 hasConceptScore W2599957194C2778424827 @default.
- W2599957194 hasConceptScore W2599957194C2779742542 @default.
- W2599957194 hasConceptScore W2599957194C2780456651 @default.
- W2599957194 hasConceptScore W2599957194C2781413609 @default.
- W2599957194 hasConceptScore W2599957194C509974204 @default.
- W2599957194 hasConceptScore W2599957194C71924100 @default.
- W2599957194 hasConceptScore W2599957194C90924648 @default.
- W2599957194 hasLocation W25999571941 @default.
- W2599957194 hasOpenAccess W2599957194 @default.
- W2599957194 hasPrimaryLocation W25999571941 @default.
- W2599957194 isParatext "false" @default.
- W2599957194 isRetracted "false" @default.
- W2599957194 magId "2599957194" @default.
- W2599957194 workType "article" @default.